What is Alamar Biosciences 's total current liabilities?

Alamar Biosciences (ALMR) reported total current liabilities of $24.05M in Q1 2026.

What does total current liabilities mean?

The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Alamar Biosciences ALMR Total Current Liabilities

Total Current Liabilities at other companies

SamsaraIOT

$912.13M+23.1%

Becton, Dickinson and CompanyBDX

$8.51B+10.6%

Sempra EnergySRE

$21.44B+116%

TeraWulfWULF

$2.38B+1,872%

MSCIMSCI

$1.61B+10.0%

General Purpose Acquisition Corp. GPAC

$13.86M-38.7%

Other financials

Income statement

See full

Revenue$26.0M+98.9%

Gross profit$14.5M+126%

Operating income-$12.3M-44.4%

Net income-$21.3M-178%

EPS (diluted)-$1.74-156%

Balance sheet

See full

Cash & equivalents$64.6M—

Total debt$30.6M—

Total equity-$178.1M—

Total assets$186.5M—

Cash flow

See full

Operating cash flow-$20.3M-55.7%

CapEx$600.0K+8.3%

Free cash flow-$20.9M-53.8%

Valuation

See full

Market cap$1.52B—

Enterprise value$1.49B—

Returns & leverage

See full

Debt / equity-0.2×—

Current ratio5.9×—

Where this comes from

Reported directly by Alamar Biosciences in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: Alamar Biosciences ’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alamar Biosciences 's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Alamar Biosciences 's total current liabilities?: Alamar Biosciences (ALMR) reported total current liabilities of $24.05M in Q1 2026.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.